Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1996-11-12
|
| pubmed:abstractText |
The objective of this multicenter phase II study was to evaluate the activity of docetaxel in previously untreated small cell lung cancer. Fourteen patients were treated at a dose of 75 mg/m2 intravenously every three weeks. Of the 12 patients evaluable for response, one had a partial response for a duration of 12 weeks for a response rate of 8.3%. Toxicity was mild. We conclude that docetaxel has, at the dose given in this study, little activity in previously untreated small cell lung cancer.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0167-6997
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
13
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
343-5
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8824354-Aged,
pubmed-meshheading:8824354-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:8824354-Carcinoma, Small Cell,
pubmed-meshheading:8824354-Drug Administration Schedule,
pubmed-meshheading:8824354-Female,
pubmed-meshheading:8824354-Humans,
pubmed-meshheading:8824354-Injections, Intravenous,
pubmed-meshheading:8824354-Lung Neoplasms,
pubmed-meshheading:8824354-Male,
pubmed-meshheading:8824354-Middle Aged,
pubmed-meshheading:8824354-Paclitaxel,
pubmed-meshheading:8824354-Taxoids
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer.
|
| pubmed:affiliation |
Hôtel-Dieu de Montréal, Qué., Canada.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|